Poly-IC enhances the effectiveness of cancer immunotherapy by promoting T cell tumor infiltration

BACKGROUND: Immunotherapies, such as immune checkpoint inhibitors and adoptive cell therapies, have revolutionized cancer treatment and resulted in complete and durable responses in some patients. Unfortunately, most immunotherapy treated patients still fail to respond. Absence of T cell infiltratio...

Descripción completa

Detalles Bibliográficos
Autores principales: Sultan, Hussein, Wu, Juan, Fesenkova, Valentyna I, Fan, Aaron E, Addis, Diane, Salazar, Andres M, Celis, Esteban
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Clinical/Translational Cancer Immunotherapy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7507896/
https://www.ncbi.nlm.nih.gov/pubmed/32958686
http://dx.doi.org/10.1136/jitc-2020-001224

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7507896/
https://www.ncbi.nlm.nih.gov/pubmed/32958686
http://dx.doi.org/10.1136/jitc-2020-001224

Ejemplares similares